Le Lézard
Classified in: Health
Subject: SVY

Global Animal Health (Pharmaceuticals, Biologicals, Medicinal Feed Additives and Diagnostics) Market Trends, Share, Size, Growth, Opportunity and Forecasts 2018-2019 & Forecast to 2024


DUBLIN, April 24, 2019 /PRNewswire/ -- The "Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global animal health market was worth more than US$ 44 Billion in 2018

Animals regularly require adequate care from their owners in order to have a good health. As the production of healthy livestock ensures safe food supply and retains the stability of consumer prices, regular monitoring of animal health and averting animal disease outbreaks have become indispensable for every country.

As effective control and prevention is necessary for limiting the spread of zoonotic diseases among animals and human beings, the animal health market is gradually gaining traction across the globe. Moreover, pet and livestock owners nowadays are willing to spend on animal healthcare products and services owing to their inflating disposable incomes, growing awareness through print and electronic media, and the emerging trend of pet humanization.

Global Animal Health Market Drivers:

Currently, the animal health industry is flourishing on account of rapid technological advancements and increasing research and development activities in the veterinary pharmaceutical industry. With the help of advanced technological systems, data produced in veterinary clinics can be now uploaded on the internet and shared with other researchers and clinicians. This technology also aids in facilitating real-time analysis of fluctuations in the prevalence of diseases. In order to optimize the veterinary healthcare sector, governments in several developed countries are also undertaking initiatives and implementing animal vaccination programs.

On account of these factors, the market value is projected to exceed US$ 58 Billion by 2024, exhibiting a CAGR of around 5% during 2019-2024.

Breakup by Animal Type:

On the basis of animal types, the market has been bifurcated into commercial and companion animals. At present, commercial animals account for the majority of the market share.

Breakup by Product Type:

Based on the product type, the animal health market has been divided into pharmaceuticals, biologicals, medicinal feed additives and diagnostics. Pharmaceuticals currently represent the largest product type.

Regional Insights:

On a geographical front, North America enjoys the leading position in the global animal health market. Other regions include Europe, Asia Pacific, Latin America, and Middle East and Africa.

Competitive Landscape:

The market is highly fragmented in nature with the presence of several small as well as large players who compete in terms of prices and quality.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Animal Health Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Animal Type
5.4 Market Breakup by Product
5.5 Market Breakup by Region
5.6 Market Forecast

6 Market Breakup by Animal Type
6.1 Commercial
6.2 Companion

7 Market Breakup by Product
7.1 Pharmaceuticals
7.2 Biologicals
7.3 Medicinal Feed Additives
7.4 Diagnostics

8 Market Breakup by Region
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Middle East and Africa
8.5 Latin America

9 Global Animal Health Industry: SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Global Animal Health Industry: Value Chain Analysis

11 Global Animal Health Industry: Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Global Animal Health Industry: Price Analysis
12.1 Price Indicators
12.2 Price Structure
12.3 Margin Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Bayer
13.3.2 Elanco
13.3.3 Merck
13.3.4 Merial
13.3.5 Zoetis Inc.
13.3.6 Biogenesis Bago
13.3.7 Boehringer Ingelheim
13.3.8 Ceva Sante Animale
13.3.9 Heska
13.3.10 Neogen
13.3.11 Novartis
13.3.12 Thermo Fisher Scientific
13.3.13 Vetoquinol
13.3.14 Virbac

For more information about this report visit https://www.researchandmarkets.com/r/cm8fg2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 11:15
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...



News published on and distributed by: